Natera
Trade Natera 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About NTRA
Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT).
NTRA Key Statistics
Stock Snapshot
The current Natera(NTRA) stock price is $200.67, with a market capitalization of 28.05B. The stock trades at a price-to-earnings (P/E) ratio of -91.72.
On 2025-11-13, Natera(NTRA) stock traded between a low of $200.34 and a high of $209.00. Shares are currently priced at $200.67, which is +0.2% above the low and -4.0% below the high.
Natera(NTRA) shares are trading with a volume of 1.44M, against a daily average of 1.65M.
During the past year, Natera(NTRA) stock moved between $125.38 at its lowest and $212.21 at its peak.
During the past year, Natera(NTRA) stock moved between $125.38 at its lowest and $212.21 at its peak.
NTRA News
Stephens raised the firm’s price target on Natera (NTRA) to $235 from $197 and keeps an Overweight rating on the shares after the company reported “another stro...
As the U.S. market experiences mixed outcomes with the Dow Jones Industrial Average reaching unprecedented heights and the Nasdaq showing signs of volatility, i...
Natera announced strong third quarter results and raised its 2025 revenue guidance by US$160 million, now expecting between US$2.18 billion and US$2.26 billion,...
Analyst ratings
91%
of 22 ratingsMore NTRA News
Natera Inc. ((NTRA)) has held its Q3 earnings call. Read on for the main highlights of the call. Meet Your ETF AI Analyst Discover how TipRanks' ETF AI Analyst...
Analyst Daniel Brennan from TD Cowen maintained a Buy rating on Natera and increased the price target to $240.00 from $215.00. Meet Your ETF AI Analyst Discover...
Earnings Call Insights Natera raises 2025 revenue guidance to $2.18B–$2.26B amid record Signatera growth and increased gross margin Nov. 06, 2025 8:37 PM ET Nat...
